Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lubiprostone Sprinkle vs Capsule in CIC
NCT03097861Phase 3Completed
- Sponsor
- Sucampo
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cobiprostone in chronic idiopathic constipation (CIC) (3 arms), sponsored by Sucampo. Primary endpoint: Observed Spontaneous Bowel Movement Count at 1 week. Started Mar 2017; status: completed.
02
Drugs
cobiprostone
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT03097861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03097861.